What is the ICD-10 (International Classification of Diseases, 10th Revision) diagnosis code for unspecified dementia in a geriatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for Unspecified Dementia

The ICD-10 diagnosis code for unspecified dementia is F03.90 (unspecified dementia without behavioral disturbance) or F03.91 (unspecified dementia with behavioral disturbance). 1

When to Use Unspecified Dementia Codes

Use F03.90 or F03.91 only when the underlying etiology of dementia cannot be determined despite appropriate diagnostic evaluation. 1 This represents a diagnosis of exclusion after ruling out specific dementia subtypes.

Appropriate Clinical Scenarios

  • When diagnostic evaluation has been completed but the specific pathology (Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia) cannot be definitively established 2
  • When mixed etiology dementia is present but no single pathology predominates sufficiently to warrant a primary disease classification 2
  • When patients present with atypical or non-amnestic symptoms that don't fit standard diagnostic criteria for specific dementia types 2

Critical Coding Pitfall to Avoid

The unspecified dementia code (F03.90/F03.91) is substantially overused in clinical practice, leading to underestimation of specific dementia prevalence. 3 A study in the VA New England healthcare system found that 42.5% of first dementia diagnoses used the nonspecific code, and nearly half of individuals with persistent "unspecified dementia" actually met criteria for a specific dementia subtype upon chart review. 3

Why This Matters

  • Primary care physicians performed cognitive testing only 12% of the time when first using the unspecified dementia code, compared to 98% for specialists 3
  • Access to dementia specialists (geriatricians, neurologists) significantly reduced inappropriate use of nonspecific codes 3
  • Proper diagnostic workup should establish the underlying pathology to determine the specific F code classification, rather than defaulting to the unspecified code. 1

Preferred Alternative: Specific Dementia Codes

When the underlying etiology can be identified, use these specific codes instead:

  • F02.81: Dementia in other diseases classified elsewhere with behavioral disturbance (used for Alzheimer's disease with behavioral symptoms) 1
  • F01.51: Vascular dementia with behavioral disturbance (when cerebrovascular disease is the primary etiology) 1
  • Lewy body dementia codes: When fluctuating cognition, visual hallucinations, and behavioral symptoms are present 1

Documentation Requirements

  • The underlying pathology determines the specific classification, not just the clinical presentation 1
  • For mixed etiology dementia, document all contributing pathologies with the primary disease code listed first, followed by F02.81 1
  • Use validated assessment tools (NPI-Q, CMAI, CSDD, GAI, or PSWQ-A) to systematically assess behavioral symptoms 1

Behavioral Disturbance Modifier

Add the behavioral disturbance modifier (.91 instead of .90) when patients exhibit agitation, aggression, wandering, sexual disinhibition, mood fluctuations, apathy, social withdrawal, or socially unacceptable behaviors. 1 This distinction is clinically important for care planning and resource allocation.

References

Guideline

Dementia with Behavioral Disturbances Coding Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended diagnostic approach for a geriatric patient suspected of having dementia, considering new diagnostic technologies like liquid biopsy and nanotechnology?
What is dementia?
What is the recommended management and treatment for a 75-year-old patient with mild global parenchymal volume loss on MRI, suggestive of possible dementia or other conditions?
Is this medication or surgery medically indicated for a geriatric patient with a condition such as dementia?
What are the diagnostic criteria and management options for dementia?
What is the recommended treatment and management for a patient with a positive double-stranded DNA (dsDNA) antibody test, suggestive of Systemic Lupus Erythematosus (SLE) or other autoimmune disorders?
What is the next best medication for a patient with uncontrolled hypertension and End-Stage Renal Disease (ESRD) taking hydralazine (direct vasodilator) 50 mg three times a day (TID), nifedipine (calcium channel blocker) 90mg, and carvedilol (beta-blocker) 12.5 milligrams twice a day (BID)?
What is the diagnostic workup and treatment approach for a 16-year-old female patient with suspected Polycystic Ovary Syndrome (PCOS)?
What is the best course of action for a patient on Abilify (aripiprazole) 5mg and Depakote (valproate) 500mg who reports manageable depression but persistent anxiety?
What is the best treatment approach for a patient with a history of kidney transplant and immunosuppressive therapy, including corticosteroids, presenting with conjunctivitis (pink eye)?
Can Wegovy (semaglutide) help with symptoms of depression in patients with a history of obesity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.